Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biodesix Inc
(NQ:
BDSX
)
1.370
+0.040 (+3.01%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biodesix Inc
< Previous
1
2
3
4
5
6
7
Next >
Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to be Presented at ATS 2022 International Conference
May 12, 2022
From
Biodesix, Inc.
Via
Business Wire
Recap: Biodesix Q1 Earnings
May 11, 2022
Biodesix (NASDAQ:BDSX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Biodesix Announces First Quarter 2022 Results and Highlights
May 11, 2022
From
Biodesix, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
May 02, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
March 25, 2022
On Friday, 166 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...
Via
Benzinga
Recap: Biodesix Q4 Earnings
March 14, 2022
Biodesix (NASDAQ:BDSX) reported its Q4 earnings results on Monday, March 14, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Preview: Biodesix's Earnings
March 11, 2022
Biodesix (NASDAQ:BDSX) is set to give its latest quarterly earnings report on Monday, 2022-03-14. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
66 Biggest Movers From Yesterday
May 03, 2022
Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged...
Via
Benzinga
Biodesix to Report First Quarter 2022 Financial Results on May 11, 2022
April 27, 2022
From
Biodesix, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022
April 20, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
April 18, 2022
Gainers Rockwell Medical (NASDAQ:RMTI) stock rose 9.2% to $0.4 during Monday's after-market session. The company's market cap stands at $37.5 million.
Via
Benzinga
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
April 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
68 Biggest Movers From Yesterday
April 19, 2022
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Down Ahead Of March Inflation Report
April 12, 2022
Pre-open movers U.S. stock futures traded lower in early premarket trade after the Nasdaq Composite index closed at 13,411.96, a dip of almost 300 points. Investors are awaiting the annual inflation...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 12, 2022
Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
Why This Nano-Cap Healthcare Stock Spiked Over 80% After-Hours Today
April 12, 2022
Shares of Biodesix, Inc. (NASDAQ: BDSX), a lung disease-focused diagnostics company, skyrocketed in after-hours trading on Monday.
Via
Benzinga
Biodesix Strengthens Financial Position with Equity Issuance and Amendment to Term Loan
April 11, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Publication Further Validating the Use of Liquid Biopsies and NGS Techniques to Provide Clinical Information for Patients With Cancer
March 29, 2022
From
Biodesix, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Monday
March 28, 2022
On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 24, 2022
On Thursday, 112 stocks made new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: Stanley Black & Decker (NYSE:SWK) was the largest firm by market...
Via
Benzinga
Biodesix's Return On Capital Employed Insights
March 15, 2022
Biodesix (NASDAQ:BDSX) brought in sales totaling $7.22 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 15.36%, resulting in a loss of $13...
Via
Benzinga
Biodesix Announces Fourth Quarter and Year End 2021 Results and Highlights
March 14, 2022
From
Biodesix
Via
Business Wire
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
March 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...
Via
Benzinga
Biodesix to Report Fourth Quarter and Full Year 2021 Financial Results on March 14, 2022
February 28, 2022
From
Biodesix, Inc.
Via
Business Wire
Earnings Scheduled For March 14, 2022
March 14, 2022
Companies Reporting Before The Bell • F45 Training Holdings (NYSE:FXLV) is projected to report earnings for its fourth quarter. • The One Group Hospitality (...
Via
Benzinga
Biodesix CEO Scott Hutton Named to The Healthcare Technology Report’s List of Top 25 Biotech CEOs in 2022
February 22, 2022
From
Biodesix, Inc.
Via
Business Wire
73 Biggest Movers From Yesterday
February 23, 2022
Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE...
Via
Benzinga
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue (Unaudited)
February 14, 2022
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 09, 2022
From
Biodesix, Inc.
Via
Business Wire
64 Biggest Movers From Yesterday
February 01, 2022
Gainers Calithera Biosciences, Inc. (NASDAQ: CALA) shares surged 55.7% to settle at $0.65 on Monday after Ladenburg Thalmann initiated coverage on the stock with a...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.